Immunicom
1 known investors
Find your way into Immunicom
70 people in our graph share verified history with the Immunicom team — schools, employers, funds. One of them is your warm intro.
Dr Jonathan Avesarunlockedknows Amir Jafri · together at West Wireless Health Institute (overlapped)
×10knows the team · via Cardinal Health
knows the team · via West Wireless Health Institute
Immunicom is a biotech company developing immunotherapies based on its Immunopheresis platform, a blood-filtering device that works external to the body to treat cancer and inflammatory, cardiovascular, renal, and autoimmune diseases. Its initial focus is immuno-oncology, with CE Mark approval in Europe for advanced triple-negative breast cancer and multiple ongoing clinical trials.
Founders & leadership
AJ
Amir JafriinCEO/FounderHe has spent over 35 years in technology and healthcare leadership, including founding multiple ventures and holding roles at major biotech and medtech companies, with a background in biology and chemistry.
Investors · 1
In the news
Frequently asked questions
- What does Immunicom do?
- Immunicom is a biotech company developing immunotherapies based on its Immunopheresis platform, a blood-filtering device that works external to the body to treat cancer and inflammatory, cardiovascular, renal, and autoimmune diseases. Its initial focus is immuno-oncology, with CE Mark approval in Europe for advanced triple-negative breast cancer and multiple ongoing clinical trials.
- Who founded Immunicom?
- Immunicom was founded by Amir Jafri.
- Who are Immunicom's investors?
- Immunicom's investors include Bootstrap Venture Partners.